It has been elucidated in many cancers, such as oral cancer [23], hepatocellular carcinoma [24], lung adenocarcinoma [25], nephroblastoma [26] and osteosarcoma [27] in which SOX21-AS1 expression was testified to be higher in cancer cells. This evidence concerns the gene SOX21 and osteosarcoma.